Mitsubishi Chemical Group Corp Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
Mitsubishi Chemical Group Corp Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
DUBLIN, Feb. 2, 2024 /PRNewswire/ -- The "Mitsubishi Chemical Group Corporation - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.
都柏林,2024 年 2 月 2 日 /PRNewswire/ — “三菱化學集團公司——數字化轉型戰略” 公司簡介已添加到 ResearchandMarkets.co 提供。
This report provides insight into Mitsubishi Chemical's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts.
Mitsubishi Chemical Group Corp (MCGC), formerly Mitsubishi Chemical Holdings Corp is a diversified chemical company. Its products and services include advanced polymers, high-performance chemicals, high-performance films, advanced moldings and composites, petrochemicals, carbon, industrial gases, methyl methacrylate, and environment and living solutions.
本報告深入了解了三菱化學的技術活動,包括其數字化轉型戰略、創新計劃、技術舉措、估計的信通技術預算以及主要的信通技術合同。
三菱化學集團公司(MCGC),前身爲三菱化學控股公司,是一家多元化化學公司。其產品和服務包括先進聚合物、高性能化學品、高性能薄膜、先進模塑和複合材料、石化產品、碳、工業氣體、甲基丙烯酸甲酯以及環境和生活解決方案。
MCGC also provides ethical pharmaceuticals, diagnostic reagents and instruments, capsules and pharmaceutical equipment, active pharmaceutical ingredients and intermediates, and self-health check services. The company serves several sectors, including mobility, environment and new energy, information technology, electronics and display, medical, food and bio products, packaging, labels and films and healthcare.
In June 2022, MCHG and Plug and Play Japan launched the TANAMIN Digital Health Challenge. This challenge will accept submissions from digital health startups proposing cutting-edge technology solutions to improve well-being of ALS patients and their families, digitalize Decentralized Clinical Trial, or increase preventative vaccinations in Japan. Finalists of the challenge will be offered an opportunity to pursue a paid proof of concept with MCHG, opening a potential long-term partnership with Mitsubishi Tanabe Pharma.
Launched in December 2022, Growth Garage Business Incubator of Advanced Materials Division of Mitsubishi Chemical Group is inviting entrepreneurs, innovators and founders focused on lightweight parts and applications with carbon fiber-reinforced plastics (CFRP), to submit their idea to the composite Engineering Challenge. The winners of challenge will gain access to technology resources and support in material selection, tool design, scalability, and design for manufacturing. Additionally, the winners will also receive a support package of $25,000, access to industry experts, Mitsubishi's corporate venture capital arm and network to create global exposure.
MCGC還提供合乎道德的藥物、診斷試劑和儀器、膠囊和製藥設備、活性藥物成分和中間體,以及自我健康檢查服務。該公司爲多個行業提供服務,包括交通、環境和新能源、信息技術、電子和顯示器、醫療、食品和生物產品、包裝、標籤和薄膜以及醫療保健。
2022年6月,MCHG和即插即用日本發起了TANAMIN數字健康挑戰賽。本次挑戰賽將接受數字健康初創公司的參賽作品,這些初創公司提出尖端技術解決方案,以改善ALS患者及其家屬的福祉,數字化去中心化臨床試驗,或增加日本的預防性疫苗接種。挑戰賽的決賽選手將有機會向MCHG進行有償概念驗證,從而與三菱田邊製藥開啓潛在的長期合作伙伴關係。
三菱化學集團先進材料事業部Growth Garage企業孵化器於2022年12月啓動,邀請專注於碳纖維增強塑料(CFRP)輕質零件和應用的企業家、創新者和創始人向複合材料工程挑戰賽提交他們的想法。挑戰賽的獲勝者將獲得材料選擇、刀具設計、可擴展性和製造設計方面的技術資源和支持。此外,獲獎者還將獲得25,000美元的一攬子支持計劃,可以接觸行業專家,三菱的企業風險投資部門和網絡,以創造全球知名度。
Scope
範圍
- Mitsubishi is installing and applying digital technologies to improve business efficiency and positioned digitalization as a strategic priority in its business model to enhance customer experience and enable business transformation. The company is modernizing its approaches to maximize benefits of cloud computing, mobile devices, and next-generation network technology to tap new opportunities and enhance cost efficiencies.
- Mitsubishi is promoting digital technologies to realize precision medicine. For instance, it is collaborating with academia and AI venture companies to develop AI technology for drug screening, which enables accelerated drug evaluation using large-scale image data. The company also aims to apply this technology to drug screening based on genetic polymorphism and drug screening using human induced pluripotent stem (IPS) cells from patients.
- Mitsubishi joined the IBM Quantum Network to collaborate with IBM scientists to model and analyze the deep molecular structures of potential OLED materials on IBM Quantum devices. The research teams of Mitsubishi Chemical, Keio University, and IBM Quantum are working to better understand lithium-oxygen's potential as an energy source by using new algorithms that take advantage of quantum computing to develop lithium-oxygen batteries.
- 三菱正在安裝和應用數字技術來提高業務效率,並將數字化定位爲其商業模式的戰略重點,以增強客戶體驗和實現業務轉型。該公司正在對其方法進行現代化改造,以最大限度地發揮雲計算、移動設備和下一代網絡技術的優勢,以挖掘新機會並提高成本效率。
- 三菱正在推廣數字技術,以實現精準醫療。例如,它正在與學術界和人工智能風險投資公司合作開發用於藥物篩選的人工智能技術,從而能夠使用大規模圖像數據加速藥物評估。該公司還旨在將這項技術應用於基於遺傳多態性的藥物篩查和使用患者的人體誘導多能幹細胞(IPS)進行藥物篩查。
- 三菱加入了IBM量子網絡,與IBM的科學家合作,對IBM量子器件上潛在的OLED材料的深層分子結構進行建模和分析。三菱化學、慶應大學和IBM Quantum的研究小組正在使用利用量子計算開發鋰氧電池的新算法,努力更好地了解鋰氧作爲能源的潛力。
Reasons to Buy
購買理由
- Gain insights into Mitsubishi's tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches, partnership, investments and acquisition strategies.
- 深入了解三菱的科技運營。
- 深入了解其技術戰略和創新計劃。
- 深入了解其重點技術主題。
- 深入了解各種產品發佈、合作伙伴關係、投資和收購策略。
Key Topics Covered:
涵蓋的關鍵主題:
- Overview
- Digital Transformation Strategy
- Accelerators, Incubators, and Other Innovation Programs
- Technology Focus
- Technology Initiatives
- Venture Arm: Diamond Edge Ventures
- Investment
- Acquisitions
- Partnership, Investment & Acquisition Network Map
- ICT Budget and Contracts
- Key Executives
- Contact the Publisher
- 概述
- 數字化轉型戰略
- 加速器、孵化器和其他創新計劃
- 技術聚焦
- 技術舉措
- Venture Arm:鑽石邊緣風險投資
- 投資
- 收購
- 夥伴關係、投資和收購網絡地圖
- ICT 預算和合同
- 主要高管
- 聯繫出版商
A selection of companies mentioned in this report includes
本報告中提到的精選公司包括
- Allganize
- Kebotix
- Circularise
- AM Polymers
- Atum3D
- Ube Industries
- Dyadic International
- EditForce
- Origin Materials
- Solvay
- Dymon
- Celanese
- ENEOS
- Mura Technology
- KBR
- Agilyx
- Linde Engineering
- Allganize
- Kebotix
- 循環化
- AM 聚合物
- Atum3D
- 宇部工業
- 達迪克國際
- editForce
- 原產材料
- Solvay
- 戴蒙
- 塞拉尼人
- ENEOS
- Mura 科技
- KBR
- Agilyx
- 林德工程
For more information about this company profile visit
有關此公司簡介的更多信息,請訪問
About ResearchAndMarkets.com
關於 ResearchandMarkets
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ResearchandMarkets.com是全球領先的國際市場研究報告和市場數據來源。我們爲您提供有關國際和地區市場、關鍵行業、頂級公司、新產品和最新趨勢的最新數據。
Media Contact:
媒體聯繫人:
Research and Markets
Laura Wood, Senior Manager
[email protected]
研究與市場
勞拉·伍德,高級經理
[電子郵件保護]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
如需了解歐洲安全局的辦公時間,請致電 +1-917-300-0470
如需美國/加拿大免費電話,請致電 +1-800-526-8630
如需了解格林尼治標準時間辦公時間,請致電 +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
美國傳真:646-607-1907
傳真(美國境外):+353-1-481-1716
Logo:
徽標:
SOURCE Research and Markets
來源:研究與市場
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因